test

John R. Warren

@Farallon Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$20.437BTotal holdings153
Assets growth rate-3.56%Assets growth rate (2-Q avg)-3.73%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Farallon Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 153 positions.

Assets under management

The assets under management (AUM) of Farallon Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 20.437B in assets, with a quarterly growth rate of -3.56% and a 2-quarter average growth rate of -3.73%. The portfolio is managed by John R. Warren, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MASIMasimo Corp
Recent Activity
Increased 12.42%
0.83%
$167.804M
1.259M shares@ $133.34 avg price
THCTenet Healthcare Corp
Recent Activity
Increased 0.73%
0.57%
$115.084M
692,442 shares@ $166.2 avg price
LBPHLongboard Pharmaceuticals In
Recent Activity
Increased 7.16%
0.52%
$105.018M
3.151M shares@ $33.34 avg price
ICLRIcon Plc
Recent Activity
Increased 23.91%
0.32%
$63.438M
220,800 shares@ $287.31 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Increased 133.81%
0.3%
$59.378M
1.162M shares@ $51.1 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Increased 41%
0.23%
$45.001M
2.814M shares@ $16.0 avg price
LQDALiquidia Corporation
Recent Activity
Increased 60.15%
0.17%
$32.91M
3.291M shares@ $10.0 avg price
GDSGds Hldgs Ltd
Recent Activity
Increased 24.88%
0.16%
$31.235M
1.531M shares@ $20.4 avg price
ENTAEnanta Pharmaceuticals Inc
Recent Activity
Increased 0.64%
0.11%
$21.842M
2.108M shares@ $10.36 avg price
TECXTectonic Therapeutic Inc
Recent Activity
Increased 20.74%
0.08%
$15.768M
520,397 shares@ $30.3 avg price